We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » European Commission Again Postpones Decision on Illumina-Grail Merger
European Commission Again Postpones Decision on Illumina-Grail Merger
The European Commission has again postponed a final decision on Illumina’s $8 billion acquisition of Grail — developer of the Galleri blood test, which can detect 50 different cancers before patients are symptomatic.